(CNDT) Conduent - Overview
Stock: Business, Process, Services, Digital, Payment
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 63.9% |
| Relative Tail Risk | -8.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.45 |
| Alpha | -77.55 |
| Character TTM | |
|---|---|
| Beta | 1.032 |
| Beta Downside | 1.364 |
| Drawdowns 3y | |
|---|---|
| Max DD | 69.00% |
| CAGR/Max DD | -0.44 |
Description: CNDT Conduent December 28, 2025
Conduent Inc. (NASDAQ: CNDT) delivers outsourced digital business solutions across commercial, government, and transportation clients in the U.S., Europe, and other regions. The firm’s three operating segments are Commercial (process services, customer-experience, healthcare claims, and human-capital solutions), Government (public-assistance, healthcare program administration, digital payments, and eligibility services), and Transportation (tolling, transit, congestion-management, and vehicle-location systems). It was spun out of Xerox in 2016 and is headquartered in Florham Park, New Jersey.
Key recent metrics: FY 2023 revenue was ≈ $5.5 billion, with an operating margin of ~ 3.2 % and a backlog growth rate of 5 % YoY, reflecting steady demand for outsourced public-sector processing. The U.S. government outsourcing market has expanded ~5 % annually, while the global digital-payments ecosystem is projected to grow at a ~12 % CAGR through 2028, both of which underpin Conduent’s growth levers.
Given the firm’s exposure to fiscal-year budget cycles and regulatory reforms, analysts should monitor federal spending trends, state-level Medicaid/CHIP enrollment changes, and the rollout of mileage-based user fees, as these drivers can materially affect segment revenue volatility.
For a deeper quantitative view, you may want to explore Conduent’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -149.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.05 > 0.02 and ΔFCF/TA -2.65 > 1.0 |
| NWC/Revenue: 14.71% < 20% (prev 17.61%; Δ -2.90% < -1%) |
| CFO/TA -0.03 > 3% & CFO -71.0m > Net Income -149.0m |
| Net Debt (618.0m) to EBITDA (38.0m): 16.26 < 3 |
| Current Ratio: 1.64 > 1.5 & < 3 |
| Outstanding Shares: last quarter (161.2m) vs 12m ago -5.84% < -2% |
| Gross Margin: 17.71% > 18% (prev 0.20%; Δ 1751 % > 0.5%) |
| Asset Turnover: 115.0% > 50% (prev 123.5%; Δ -8.48% > 0%) |
| Interest Coverage Ratio: -3.12 > 6 (EBITDA TTM 38.0m / Interest Expense TTM 49.0m) |
Altman Z'' -4.49
| A: 0.18 (Total Current Assets 1.15b - Total Current Liabilities 702.0m) / Total Assets 2.50b |
| B: -1.03 (Retained Earnings -2.58b / Total Assets 2.50b) |
| C: -0.06 (EBIT TTM -153.0m / Avg Total Assets 2.67b) |
| D: -1.84 (Book Value of Equity -3.02b / Total Liabilities 1.64b) |
| Altman-Z'' Score: -4.49 = D |
Beneish M -3.02
| DSRI: 0.94 (Receivables 679.0m/823.0m, Revenue 3.07b/3.51b) |
| GMI: 1.13 (GM 17.71% / 19.98%) |
| AQI: 1.10 (AQ_t 0.40 / AQ_t-1 0.37) |
| SGI: 0.88 (Revenue 3.07b / 3.51b) |
| TATA: -0.03 (NI -149.0m - CFO -71.0m) / TA 2.50b) |
| Beneish M-Score: -3.02 (Cap -4..+1) = AA |
What is the price of CNDT shares?
Over the past week, the price has changed by +7.91%, over one month by -25.00%, over three months by -32.43% and over the past year by -61.93%.
Is CNDT a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CNDT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 7 | 366.7% |
| Analysts Target Price | 7 | 366.7% |
| ValueRay Target Price | 1.1 | -28.7% |
CNDT Fundamental Data Overview February 03, 2026
P/B = 0.3092
P/EG = 4.44
Revenue TTM = 3.07b USD
EBIT TTM = -153.0m USD
EBITDA TTM = 38.0m USD
Long Term Debt = 697.0m USD (from longTermDebt, last quarter)
Short Term Debt = 68.0m USD (from shortTermDebt, last quarter)
Debt = 882.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 618.0m USD (from netDebt column, last quarter)
Enterprise Value = 837.6m USD (219.6m + Debt 882.0m - CCE 264.0m)
Interest Coverage Ratio = -3.12 (Ebit TTM -153.0m / Interest Expense TTM 49.0m)
EV/FCF = -7.04x (Enterprise Value 837.6m / FCF TTM -119.0m)
FCF Yield = -14.21% (FCF TTM -119.0m / Enterprise Value 837.6m)
FCF Margin = -3.87% (FCF TTM -119.0m / Revenue TTM 3.07b)
Net Margin = -4.85% (Net Income TTM -149.0m / Revenue TTM 3.07b)
Gross Margin = 17.71% ((Revenue TTM 3.07b - Cost of Revenue TTM 2.53b) / Revenue TTM)
Gross Margin QoQ = 17.73% (prev 18.17%)
Tobins Q-Ratio = 0.34 (Enterprise Value 837.6m / Total Assets 2.50b)
Interest Expense / Debt = 1.36% (Interest Expense 12.0m / Debt 882.0m)
Taxrate = 15.48% (78.0m / 504.0m)
NOPAT = -129.3m (EBIT -153.0m * (1 - 15.48%)) [loss with tax shield]
Current Ratio = 1.64 (Total Current Assets 1.15b / Total Current Liabilities 702.0m)
Debt / Equity = 1.03 (Debt 882.0m / totalStockholderEquity, last quarter 859.0m)
Debt / EBITDA = 16.26 (Net Debt 618.0m / EBITDA 38.0m)
Debt / FCF = -5.19 (negative FCF - burning cash) (Net Debt 618.0m / FCF TTM -119.0m)
Total Stockholder Equity = 854.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -5.58% (Net Income -149.0m / Total Assets 2.50b)
RoE = -17.44% (Net Income TTM -149.0m / Total Stockholder Equity 854.2m)
RoCE = -9.86% (EBIT -153.0m / Capital Employed (Equity 854.2m + L.T.Debt 697.0m))
RoIC = -8.93% (negative operating profit) (NOPAT -129.3m / Invested Capital 1.45b)
WACC = 2.86% (E(219.6m)/V(1.10b) * Re(9.72%) + D(882.0m)/V(1.10b) * Rd(1.36%) * (1-Tc(0.15)))
Discount Rate = 9.72% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -13.14%
Fair Price DCF = unknown (Cash Flow -119.0m)
EPS Correlation: -70.51 | EPS CAGR: -12.20% | SUE: -0.06 | # QB: 0
Revenue Correlation: -91.97 | Revenue CAGR: -7.99% | SUE: -1.36 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.09 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=1